Cargando…
Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions
This review on COVID-19 immunotherapy enables a comparative analysis of the short-list of currently approved major vaccines. These include the Pfizer and Moderna first mRNA vaccines under FDA purview and the Oxford/AstraZeneca simian adenovirus-vectored vaccine (under UK-MHPRA guidance), all produce...
Autor principal: | Putter, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881713/ https://www.ncbi.nlm.nih.gov/pubmed/33610448 http://dx.doi.org/10.1016/j.transci.2021.103093 |
Ejemplares similares
-
Editorial: The Immunology of Adverse Drug Reactions
por: Illing, Patricia T., et al.
Publicado: (2022) -
Editorial: NK cells in viral immunology and immunotherapy
por: Mulik, Sachin, et al.
Publicado: (2023) -
Immunologic adverse reactions of β-blockers and the skin
por: Tatu, Alin Laurentiu, et al.
Publicado: (2019) -
Harnessing immunological targets for COVID-19 immunotherapy
por: Mehata, Abhishesh Kumar, et al.
Publicado: (2021) -
COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)